Formulation

Oct 01, 2016
BioPharm International
An approach to stabilize PBS-based formulations could provide a simple physiological solution for use of proteins in research, preclinical, diagnostics, and clinical studies, as well as commercial biotherapeutic products.
Oct 01, 2016
BioPharm International
Challenging molecules and markets are driving the development of new solutions for drug delivery.
Oct 01, 2016
BioPharm International
Multiparticulates are increasingly used due to their flexibility in providing controlled-release, fixed-dose combinations, ease of taste-masking, and suitability for pediatric applications
Oct 01, 2016
BioPharm International
High-purity low-endotoxin sugars improve robustness and stability of protein formulation and improve drug product quality.
Jul 28, 2016
By BioPharm International Editors
NIST’s monoclonal antibody reference material can be used as a standard for biopharmaceutical analytical quality control.
Jul 28, 2016
Amgen discussed the drug-delivery approaches to two of its biologics in a recent second-quarter earnings call.
Jul 14, 2016
A new study examines the oral delivery of protein drugs in plant cells and hypothesizes that the cold storage and transportation of biologics could someday be eliminated.
Jul 01, 2016
BioPharm International
The author addresses critical issues to consider prior to performing forced degradation studies and provides best practice recommendations for these types of studies.
Jul 01, 2016
BioPharm International
The authors present an overview of the types of RNA-based therapeutics in existence and their optimal methods of manufacture, purification, formulation, and delivery.
Jun 17, 2016
In a lawsuit against Celltrion, Janssen alleges the GE subsidiary infringed one of Janssen’s patents covering the method of making the cell-culture media that HyClone later supplied to Celltrion.
native1_300x100
lorem ipsum